发明名称 NT-proCNP AS A BIOMARKER OF VASCULAR DISORDERS AND PREGNANCY COMPLICATION
摘要 The present disclosure relates to methods for the prognosis and/or diagnosis of vascular-related disorders in a subject and in particular pregnancy-related vascular disorders. The present disclosure is based on the finding that a positive correlation exists between positive prediction of a vascular disorder event in a subject and the concentration of the circulating marker NTproCNP (also referred to as NT-CNP) in humans and animals. In addition, the present disclosure is based on the finding that there is also a positive correlation between the occurrence of a vascular-related adverse event during pregnancy and the concentration of the circulating marker NT-proCNP in the maternal circulation.
申请公布号 US2015241451(A1) 申请公布日期 2015.08.27
申请号 US201314421423 申请日期 2013.08.13
申请人 Otago Innovation Limited 发明人 Espiner Eric Arnold;Prickett Timothy Charles Ramsey
分类号 G01N33/68;C07K16/22 主分类号 G01N33/68
代理机构 代理人
主权项 1. A method of predicting an adult subject's risk of acquiring a vascular disorder, comprising: (i) measuring N-terminal pro-C-type natriuretic peptide (NTproCNP) in a biological sample from the subject, and (ii) comparing the measured level of NTproCNP against a reference interval from a suitable control population, wherein an increase in the circulating level of NTproCNP compared with the control population is predictive of acquiring a vascular disorder, and further wherein said measuring step comprises detecting binding between NTproCNP and a binding agent that selectively binds to NTproCNP.
地址 Dunedin NZ
您可能感兴趣的专利